Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.33 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.33 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Diethyl Hydrogen Phosphate SCHEMBL5069693 | 0.84 | NPSR1 (0.35) | CA2NPSR1GABRA1GABRB2PTPN5 | |
| SCHEMBL1285882 | 0.81 | CA2 (0.46) | CA2NPSR1GABRA1GABRB2ALDH1A1 | |
| SCHEMBL29688753 | 0.81 | CA2 (0.46) | CA2NPSR1GABRA1GABRB2ALDH1A1 | |
| Hydrochloric Acid SCHEMBL5073192 | 0.79 | CA2 (0.44) | CA2NPSR1GABRA1GABRB2ALDH1A1 | |
| Methanesulfonic Acid Methyl Ester SCHEMBL5073212 | 0.78 | CA2 (0.34) | CA2GABRA1GABRB2ALDH1A1TSHR | |
| SCHEMBL6544073 | 0.77 | CA2 (0.41) | CA2NPSR1GABRA1GABRB2ALDH1A1 | |
| Malonic Acid SCHEMBL29009140 | 0.74 | RBP4 (0.40) | CA2NPSR1GABRA1GABRB2ALDH1A1 | |
| Trifluoromethanesulfonic Acid SCHEMBL1286190 | 0.73 | CA2 (0.37) | CA2GABRA1GABRB2PTPN5ALDH1A1 | |
| Dichloroacetic Acid SCHEMBL6037446 | 0.73 | CA2 (0.37) | CA2NPSR1GABRA1GABRB2ALDH1A1 | |
| SCHEMBL15352129 | 0.72 | CA2 (0.39) | CA2NPSR1GABRA1GABRB2PTPN5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7335787-B2 | Method for producing onium salt derivatives, and novel onium salt derivatives | TOYO GOSEI KOGYO CO., LTD. (JP) | 2008-02-26 | — | — | US | disclosed |
| US-20050176982-A1 | Method for producing onium salt derivatives, and novel onium salt derivatives | TOYO GOSEI KOGYO CO., LTD. (JP) | 2005-08-11 | — | — | US | disclosed |
| US-6620957-B1 | Process for producing onium salt derivative and novel onium salt derivative | TOYO GOSEI KOGYO CO., LTD. (JP) | 2003-09-16 | — | — | US | disclosed |
| EP-1164127-A1 | PROCESS FOR PRODUCING ONIUM SALT DERIVATIVE AND NOVEL ONIUM SALT DERIVATIVE | Toyo Gosei Kogyo Co., Ltd. (JP) | 2001-12-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050176982-A1 | Method for producing onium salt derivatives, and novel onium salt derivatives | STS, NANS, GRIK5 | CA2 6/4885NPSR1 1269/4885GABRA1 520/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.